Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

NCT00097084 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin detemir
DRUG: insulin glargine
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S